Search

Author/Creator Huang, Xiangning

1. Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. Issue 10 (1st April 2023)

Authors:
Herbst, Roy S.; Wu, Yi-Long; John, Thomas; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W.; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vu, Huu Vinh; Lu, Shun; Lee, Kye Young; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laur...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 10(2023)
Page Start:
1830
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer. (December 2018)

Authors:
John, Thomas; Akamatsu, Hiroaki; Delmonte, Angelo; Su, Wu-Chou; Lee, Jong Seok; Chang, Gee-Chen; Huang, Xiangning; Jenkins, Suzanne; Wu, Yi-Long
Journal:
Lung cancer
Issue:
Volume 126(2018)
Page Start:
133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer. Issue 2 (26th November 2019)

Authors:
Papadimitrakopoulou, Vassiliki A.; Han, Ji‐Youn; Ahn, Myung‐Ju; Ramalingam, Suresh S.; Delmonte, Angelo; Hsia, Te‐Chun; Laskin, Janessa; Kim, Sang‐We; He, Yong; Tsai, Chun‐Ming; Hida, Toyoaki; Maemondo, Makoto; Kato, Terufumi; Jenkins, Suzanne; Patel, Sabina; Huang, Xiangning; Laus, Gianluca; Mar...
Journal:
Cancer
Issue:
Volume 126:Issue 2(2020)
Page Start:
373
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗